日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response

胃食管腺癌围手术期化疗免疫疗法的II期临床试验:M2巨噬细胞群在预测疗效中的作用

Alcindor, Thierry; Tankel, James; Fiset, Pierre-Olivier; Pal, Sanjima; Opu, Touhid; Strasser, Michael; Dehghani, Mehrnoush; Bertos, Nicholas; Zuo, Dongmei; Mueller, Carmen; Cools-Lartigue, Jonathan; Hickeson, Marc; Marcus, Victoria; Camilleri-Broet, Sophie; Spatz, Alan; Evaristo, Gertruda; Farag, Mina; Artho, Giovanni; Elkrief, Arielle; Saleh, Ramy; Bailey, Swneke; Park, Morag; Huang, Sui; Sangwan, Veena; Ferri, Lorenzo

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncology.

患者来源的食管腺癌器官芯片:用于功能性精准肿瘤学的生理相关平台

Pal Sanjima, Shimshoni Elee, Torres Salvador Flores, Kong Mingyang, Tai Kulsum, Sangwan Veena, Bertos Nicholas, Bailey Swneke Donovan, Bérubé Julie, Ingber Donald E, Ferri Lorenzo

Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts

低剂量 Hsp90 抑制剂选择性地增强 HNSCC 和胰腺异种移植的放射敏感性

Ranjit K Mehta #, Sanjima Pal #, Koushik Kondapi, Merna Sitto, Cuyler Dewar, Theresa Devasia, Matthew J Schipper, Dafydd G Thomas, Venkatesha Basrur, Manjunath P Pai, Yoshihiro Morishima, Yoichi Osawa, William B Pratt, Theodore S Lawrence, Mukesh K Nyati

Data on sulforaphane treatment mediated suppression of autoreactive, inflammatory M1 macrophages

关于萝卜硫素治疗介导抑制自身反应性炎症 M1 巨噬细胞的数据

Sanjima Pal, V Badireenath Konkimalla